These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627 [TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Gerges SH; Wahdan SA; Elsherbiny DA; El-Demerdash E Life Sci; 2021 Apr; 271():119220. PubMed ID: 33592199 [TBL] [Abstract][Full Text] [Related]
26. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870 [TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. Carr RM; Oranu A; Khungar V Gastroenterol Clin North Am; 2016 Dec; 45(4):639-652. PubMed ID: 27837778 [TBL] [Abstract][Full Text] [Related]
28. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874 [TBL] [Abstract][Full Text] [Related]
29. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic fatty liver disease - current status and future directions. Demir M; Lang S; Steffen HM J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351 [TBL] [Abstract][Full Text] [Related]
31. [Non-alcoholic fatty liver disease (NAFLD)]. Rau M; Weiss J; Geier A Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253 [TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV. Verna EC Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):211-223. PubMed ID: 28404136 [TBL] [Abstract][Full Text] [Related]
33. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease]. Zhu C; Zhou D; Fan J Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471 [TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model". Fang YL; Chen H; Wang CL; Liang L World J Gastroenterol; 2018 Jul; 24(27):2974-2983. PubMed ID: 30038464 [TBL] [Abstract][Full Text] [Related]
35. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery. Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982 [TBL] [Abstract][Full Text] [Related]
36. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Yki-Järvinen H Lancet Diabetes Endocrinol; 2014 Nov; 2(11):901-10. PubMed ID: 24731669 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. Qureshi K; Abrams GA Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683 [TBL] [Abstract][Full Text] [Related]
38. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD). Johnston MP; Patel J; Byrne CD Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662 [TBL] [Abstract][Full Text] [Related]
39. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies. Pallayova M; Taheri S Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857 [TBL] [Abstract][Full Text] [Related]